Sean P. Gramling

Array ( [id] => 2832139 [patent_doc_number] => 05175256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-29 [patent_title] => 'Protein labeling reagents' [patent_app_type] => 1 [patent_app_number] => 7/590180 [patent_app_country] => US [patent_app_date] => 1990-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6073 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/175/05175256.pdf [firstpage_image] =>[orig_patent_app_number] => 590180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2869643 [patent_doc_number] => 05153312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-06 [patent_title] => 'Oligosaccharide conjugate vaccines' [patent_app_type] => 1 [patent_app_number] => 7/590649 [patent_app_country] => US [patent_app_date] => 1990-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 12145 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/153/05153312.pdf [firstpage_image] =>[orig_patent_app_number] => 590649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2787654 [patent_doc_number] => 05155210 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => 'Methods of conjugating actinomycin D' [patent_app_type] => 1 [patent_app_number] => 7/580835 [patent_app_country] => US [patent_app_date] => 1990-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5848 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/155/05155210.pdf [firstpage_image] =>[orig_patent_app_number] => 580835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2974850 [patent_doc_number] => 05194594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-16 [patent_title] => 'Modified antibodies' [patent_app_type] => 1 [patent_app_number] => 7/579375 [patent_app_country] => US [patent_app_date] => 1990-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9475 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/194/05194594.pdf [firstpage_image] =>[orig_patent_app_number] => 579375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3608943 [patent_doc_number] => 05565205 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 7/568427 [patent_app_country] => US [patent_app_date] => 1990-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9769 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565205.pdf [firstpage_image] =>[orig_patent_app_number] => 568427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2862980 [patent_doc_number] => 05082929 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-21 [patent_title] => 'Immobilization of glycocompounds and glycoconjugates' [patent_app_type] => 1 [patent_app_number] => 7/564908 [patent_app_country] => US [patent_app_date] => 1990-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4277 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/082/05082929.pdf [firstpage_image] =>[orig_patent_app_number] => 564908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2860142 [patent_doc_number] => 05084560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-28 [patent_title] => 'Immunoconjugates and methods for their use in tumor therapy' [patent_app_type] => 1 [patent_app_number] => 7/564387 [patent_app_country] => US [patent_app_date] => 1990-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7800 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/084/05084560.pdf [firstpage_image] =>[orig_patent_app_number] => 564387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3040610 [patent_doc_number] => 05334379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-02 [patent_title] => 'Cytokine and hormone carriers for conjugate vaccines' [patent_app_type] => 1 [patent_app_number] => 7/553901 [patent_app_country] => US [patent_app_date] => 1990-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 5874 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/334/05334379.pdf [firstpage_image] =>[orig_patent_app_number] => 553901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2825282 [patent_doc_number] => 05095097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-10 [patent_title] => 'Magnetic protein conjugates, a process for the preparation thereof and the use thereof' [patent_app_type] => 1 [patent_app_number] => 7/538753 [patent_app_country] => US [patent_app_date] => 1990-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3666 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/095/05095097.pdf [firstpage_image] =>[orig_patent_app_number] => 538753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2821495 [patent_doc_number] => 05116612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-26 [patent_title] => 'Immunotherapy agents for treatment of IgE mediated allergies' [patent_app_type] => 1 [patent_app_number] => 7/534237 [patent_app_country] => US [patent_app_date] => 1990-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6888 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/116/05116612.pdf [firstpage_image] =>[orig_patent_app_number] => 534237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2787691 [patent_doc_number] => 05155212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => 'Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit' [patent_app_type] => 1 [patent_app_number] => 7/529988 [patent_app_country] => US [patent_app_date] => 1990-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 32 [patent_no_of_words] => 13669 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/155/05155212.pdf [firstpage_image] =>[orig_patent_app_number] => 529988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2841884 [patent_doc_number] => 05171846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-15 [patent_title] => 'Method of preferential labelling of a phycobiliprotein with a second dye for use in a multiple color assay and product for such use' [patent_app_type] => 1 [patent_app_number] => 7/526387 [patent_app_country] => US [patent_app_date] => 1990-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1657 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/171/05171846.pdf [firstpage_image] =>[orig_patent_app_number] => 526387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2908935 [patent_doc_number] => 05216130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-01 [patent_title] => 'Complex for in-vivo target localization' [patent_app_type] => 1 [patent_app_number] => 7/525258 [patent_app_country] => US [patent_app_date] => 1990-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 5901 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/216/05216130.pdf [firstpage_image] =>[orig_patent_app_number] => 525258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3409658 [patent_doc_number] => 05443832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response' [patent_app_type] => 1 [patent_app_number] => 7/510154 [patent_app_country] => US [patent_app_date] => 1990-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2728 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443832.pdf [firstpage_image] =>[orig_patent_app_number] => 510154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2880384 [patent_doc_number] => 05185433 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-09 [patent_title] => 'Cross-linking protein compositions having two or more identical binding sites' [patent_app_type] => 1 [patent_app_number] => 7/506122 [patent_app_country] => US [patent_app_date] => 1990-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8492 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/185/05185433.pdf [firstpage_image] =>[orig_patent_app_number] => 506122 [rel_patent_id] =>[rel_patent_doc_number] =>)